Skip to main content

10-19-2017 | Retinopathy | Review | Article

Diabetic retinopathy: research to clinical practice

Clinical Diabetes and Endocrinology

Authors: Anjali R. Shah, Thomas W. Gardner

Publisher: BioMed Central



Diabetic Retinopathy (DR) is a leading cause of visual impairment in the United States. The CDC estimates that the prevalence of DR will triple from 2005 to 2050.

Main body

The report summarizes major past advances in diabetes research and their impact on clinical practice. Current paradigms and future directions are also discussed.


DR is a leading cause of visual impairment in the US. Significant progress has been made in the understanding and treatment of DR, but rising prevalence demands innovative approaches to management in the future.

Addressing suicide risk in diabetes

Learn about rates and risk, underlying psychological factors, and practical actions to support patients.